+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Canada Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Others

  • PDF Icon

    Report

  • 46 Pages
  • June 2024
  • Region: Canada
  • GlobalData
  • ID: 5201797
Description Jump to:
The “Canada Cardiac Rhythm Management Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Canada Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Others.

The Canada Cardiac Rhythm Management Devices Market report provides key information and data on :

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Cardiac Rhythm Management Devices Market.
  • Global corporate-level profiles of key companies operating within the Canada Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Canada Cardiac Rhythm Management Devices is segmented as follows :

  • Cardiac Resynchronisation Therapy (CRT)
  • Pacemakers
  • Implantable Cardioverter Defibrillators (ICD)
  • Implantable Loop Recorders (ILR)

Reasons to Buy

Canada Cardiac Rhythm Management Devices Market report helps you to develop :

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Rhythm Management Devices Market, Canada
3.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2018-2033
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2018-2033
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2018-2033
3.4 Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), 2023
3.5 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in Canada, Cardiac Rhythm Management Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Biotronik SE & Co KG
4.4.1 Company Overview
4.5 MicroPort Scientific Corp
4.5.1 Company Overview
5 Cardiac Rhythm Management Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Ventripoint Diagnostics Raises USD0.69 Million in First Tranche Non-Brokered Private Placement of 10% Convertible Debenture Due 2027
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 05, 2024: Ventripoint Begins 2024 with Leadership Change
7.1.2 Jan 21, 2024: Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board
7.1.3 Oct 23, 2023: Ventripoint to Hold Annual General Meeting of Shareholders on November 1, 2023
7.1.4 Oct 03, 2023: Ventripoint Announces Appointment of Chief Finance Officer
7.2 Financial Announcements
7.2.1 Mar 28, 2024: Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call
7.2.2 Mar 22, 2024: Concha Receives FDA 510(k) Clearance for Sol Hearing Aid (CL-1001)
7.2.3 Nov 24, 2023: Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar
7.2.4 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.2.5 Aug 25, 2023: Ventripoint Announces Date and Timing for Release of Q2 2023 Financial Results and Webinar
7.2.6 Aug 09, 2023: Fluidai’s Artificial Intelligence-Powered Postsurgical Monitor, Stream Platform, Launches Globally
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 3: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 4: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 5: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2018-2033
Table 6: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2018-2033
Table 7: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2018-2033
Table 8: Pacemakers Market, Canada, Volume (Units), 2018-2033
Table 9: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2018-2033
Table 10: Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023
Table 11: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
Table 12: Cardiac Rhythm Management Devices Market Pipeline Products
Table 13: Ventripoint Diagnostics Raises USD0.69 Million in First Tranche Non-Brokered Private Placement of 10% Convertible Debenture Due 2027
Table 14: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 4: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 5: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2018-2033
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2018-2033
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2018-2033
Figure 8: Pacemakers Market, Canada, Volume (Units), 2018-2033
Figure 9: Cardiac Rhythm Management Devices Market, Canada, Company Share (%) 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Abbott Laboratories
  • Boston Scientific Corp
  • Biotronik SE & Co KG

Related Topics

Related Reports

North America Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Others - Product Image

North America Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Others

  • Report
  • 127 Pages
  • North America
From
Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 - Product Image

Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

  • Report
  • Global
From
Cardiac Rhythm Management Devices Patent Landscape Report - Product Image

Cardiac Rhythm Management Devices Patent Landscape Report

  • Report
  • 200 Pages
  • Global
From
Cardiac Rhythm Management Devices Market by Product, End-User - Global Forecast 2025-2030 - Product Image

Cardiac Rhythm Management Devices Market by Product, End-User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) - Forecast to 2029 - Product Image

Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) - Forecast to 2029

  • Report
  • 298 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.